Evaluation of antibiotic treatment decisions in pediatric intensive care units in Saudi Arabia: A national survey.


Journal

Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 31 03 2021
revised: 25 05 2021
accepted: 15 08 2021
pubmed: 4 9 2021
medline: 22 9 2021
entrez: 3 9 2021
Statut: ppublish

Résumé

To describe variables used by Saudi pediatric intensivists to make antibiotic-related decisions for children with suspected severe bacterial infections. We conducted a cross-sectional survey, which was developed using a multi-step methodological approach. The survey included 4 clinical scenarios of the most relevant bacterial infections in pediatric critical care (pneumonia, sepsis, meningitis and intra-abdominal infection). The potential determinants of antibiotic treatment duration addressed in all scenarios included clinical variables (patient characteristics, disease severity), laboratory infection markers, radiologic findings, and pathogens. The response rate was 65% (55/85). Eight variables (immunodeficiency, 3 months of age, 2 or more organ dysfunctions, Pediatric Risk of Mortality III score >10, leukocytosis, elevated C-reactive protein [CRP], elevated erythrocyte sedimentation rate [ESR], and elevated procalcitonin [PCT]) were associated with prolonging antibiotic treatment duration for all 4 clinical scenarios, with a median increase ranging from 3.0 days (95% confidence interval [CI] 0.5, 3.5, leukocytosis) to 8.8 days (95% CI 5.5, 10.5, immunodeficiency). There were no variables that were consistently associated with shortening antibiotic duration across all scenarios. Lastly, the proportion of physicians who would continue antibiotics for ≥5 days despite a positive viral polymerase chain reaction test result was 67% for pneumonia, 85% for sepsis, 63% for meningitis, and 95% for intra-abdominal infections. Antibiotic-related decisions for critically ill patients are complex and depend on several factors. Saudi pediatric intensivists will use prolonged courses of antibiotics for younger patients, patients with severe clinical picture, and patients with persistently elevated laboratory markers and hospital acquired infections, even when current literature and guidelines do not suggest such practices. Antimicrobial stewardship programs should include interventions to address these misconceptions to ensure the rational use of antibiotics in pediatric intensive care units.

Identifiants

pubmed: 34479076
pii: S1876-0341(21)00240-9
doi: 10.1016/j.jiph.2021.08.021
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1254-1262

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Yasser M Kazzaz (YM)

Department of Pediatrics, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; King Saud Bin Abdulaziz University-Health Sciences, Riyadh, Saudi Arabia. Electronic address: kazzazy@ngha.med.sa.

Musaed Alharbi (M)

Department of Pediatrics, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; King Saud Bin Abdulaziz University-Health Sciences, Riyadh, Saudi Arabia.

Kim C Nöel (KC)

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.

Caroline Quach (C)

Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Canada.

Douglas F Willson (DF)

Department of Pediatrics, Virginia Commonwealth University, Richmond, USA.

Elaine Gilfoyle (E)

Division of Pediatric Critical Care, Department of Pediatrics, University of Toronto, Toronto, Canada.

James D McNally (JD)

Department of Pediatrics, University of Ottawa, Ottawa, Canada.

Shauna O'Donnell (S)

Research Institute of the McGill University Health Centre, Montreal, Canada.

Jesse Papenburg (J)

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada; Division of Pediatric Infectious Diseases, Department of Pediatrics, McGill University, Montreal, Canada; Division of Microbiology, Department of Clinical Laboratory Medicine, McGill University Health Centre, Montreal, Canada.

Jacques Lacroix (J)

Department of Pediatrics, Université de Montréal, Montreal, Canada.

Patricia S Fontela (PS)

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada; Division of Pediatric Critical Care, Department of Pediatrics, McGill University, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH